Efficacy and Clinical Outcomes of Levosimendan in E-CPR

Clinical trial NCT05730907 · UNKNOWN

Trial details

NCT number: NCT05730907
Sponsor: Hamad Medical Corporation
Status: UNKNOWN
Study type: OBSERVATIONAL

Cardiogenic Shock Extracorporeal Membrane Oxygenation Complication

Start date: 2023-02-20
Primary completion: 2023-04-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.